Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rabye Ouaja"'
Autor:
Fabrice Kasiborski, Gilles Della Corte, Angelo Schenone, Dario Cocito, Sonia Pujol, Eduardo Nobile-Orazio, Rabye Ouaja, Robert Bonek
Publikováno v:
Journal of the Peripheral Nervous System
This prospective, multicenter, single‐arm, open‐label phase 3 study aimed to evaluate the efficacy and safety of IqYmune in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Patients received one induction dose of 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ced7db739c394c7aa2fad031ffa32685
http://europepmc.org/articles/PMC7754365
http://europepmc.org/articles/PMC7754365
Autor:
Ingemar S. J. Merkies, Dario Cocito, Rabye Ouaja, Haider Katifi, Jean Marc Léger, Jean-Marie Grouin, Yusuf A. Rajabally, Eduardo Nobile-Orazio, Ousmane Alfa Cissé, Jean Pouget, Teresa Sevilla
Publikováno v:
Journal of the Peripheral Nervous System
Intravenous immunoglobulin (IVIg) is the gold-standard for maintenance treatment of multifocal motor neuropathy (MMN). This phase III, randomised, double-blind, multi-centre, active-control, crossover study, aimed to evaluate the non-inferiority of I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052a372f4cd6bd99302ec8373e3ff7de
http://europepmc.org/articles/PMC6590491
http://europepmc.org/articles/PMC6590491
Autor:
Ousmane Alfa Cissé, Alain Sadoun, Jean-François Viallard, Anait L. Melikyan, Dariusz Woszczyk, Rabye Ouaja, Francesco Rodeghiero, Borhane Slama, Abdulgabar Salama
Publikováno v:
Journal of Hematology
Background: Intravenous immunoglobulin (IVIG) IQYMUNE® is a highly purified 10% IVIG that was assessed using the new stringent definition of response described in the revised guideline on the clinical investigation of IVIG. The efficacy and the safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce272dc448eda6a9c00d1f0fab8ae2e4
http://europepmc.org/articles/PMC7155829
http://europepmc.org/articles/PMC7155829
Autor:
Gergely, Krivan, Stephen, Jolles, Eduardo Lopes, Granados, Phillipe, Paolantonacci, Rabye, Ouaja, Ousmane Alfa, Cissé, Ewa, Bernatowska
Publikováno v:
American journal of clinical and experimental immunology. 6(5)
Immunoglobulin replacement therapy (IRT) is standard treatment for patients with primary immunodeficiency (PID). Because most of the patients with PID will require long life-time immunoglobulin replacement therapy, the quality of the prescribed produ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30e92ff5d936dbfc48a5d7ec42d79963
https://pubmed.ncbi.nlm.nih.gov/29181272
https://pubmed.ncbi.nlm.nih.gov/29181272
Autor:
Borhane, Slama, Olivier, Fain, Hervé, Maisonneuve, Eric, Jourdan, Jean-François, Viallard, Rabye, Ouaja, Ousmane, Alfa-Cissé, Bertrand, Godeau
Publikováno v:
American journal of blood research. 7(1)
The present study was designed to assess the efficacy and safety of IGNG that is a new liquid, saccharose and maltose-free highly purified ready-to-use 5% intravenous immunoglobulin (IVIg), in primary immune thrombocytopenic patients with severe thro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::52458c8d6d35ac51ae184d34cbac313b
https://pubmed.ncbi.nlm.nih.gov/28690918
https://pubmed.ncbi.nlm.nih.gov/28690918
Publikováno v:
Journal of the Peripheral Nervous System. Jul2022 Supplement S1, Vol. 27, pS4-S183. 180p.